Compare HZO & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HZO | TNDM |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1998 | 2013 |
| Metric | HZO | TNDM |
|---|---|---|
| Price | $52.45 | $17.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 25 |
| Target Price | ★ $49.40 | $27.76 |
| AVG Volume (30 Days) | 692.1K | ★ 1.8M |
| Earning Date | 11-12-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $2,309,288,000.00 | $1,014,736,000.00 |
| Revenue This Year | N/A | $5.69 |
| Revenue Next Year | $4.38 | $12.35 |
| P/E Ratio | $250.60 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $21.42 | $12.26 |
| 52 Week High | $52.65 | $29.65 |
| Indicator | HZO | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 55.88 |
| Support Level | $52.16 | $14.66 |
| Resistance Level | $52.45 | $18.13 |
| Average True Range (ATR) | 0.15 | 0.85 |
| MACD | -0.11 | 0.25 |
| Stochastic Oscillator | 72.22 | 98.56 |
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S and international market.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.